Fas-independent apoptosis of activated T cells induced by antibodies to the HLA class I α1 domain

Blood

Volumn 90, Issue 9, 1997, Pages 3629-3639

  Genestier, Laurent ^b   Paillot, Romain ^b   Bonnefoy Berard, Nathalie ^b   Meffre, Geneviéve ^b   Flacher, Monique ^b   Fèvre, David ^b   Liu, Yong Jun ^b   Bouteiller, Philippe Le ^b   Waldmann, Herman ^b   Engelhard, Victor H ^b   Banchereau, Jacques ^b   Revillard, Jean Pierre ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; DNA FRAGMENT; EPITOPE; FAS ANTIGEN; HLA ANTIGEN CLASS 1; MONOCLONAL ANTIBODY; PHOSPHATIDYLSERINE;

ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; DIAGNOSIS; ETIOLOGY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LYMPHOCYTE PROLIFERATION; MEMBRANE POTENTIAL; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0030822413     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.9.3629     Document Type: Article

References (60)

1. Ploegh HL, Orr HT, Strominger JL: Major histocompatibility antigens. The human (HLA-A, -B, -C) and murine (H-2K, H-2D) class I molecules. Cell 24:287, 1981
2. Le Bouteiller P: HLA class I chomosomal region genes and products: Facts and questions. Crit Rev Immunol 14:89, 1994
3. Parham P, Ohta T: Population biology of antigen presentation by MHC class I molecules. Science 272:67, 1996
4. Bjorkman PJ, Saper MA, Samaraoui B, Bennett WS, Strominger JL, Wiley DC: The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 329:512, 1987
5. Salter RD, Benjamin RJ, Wesley PK, Buxton SE, Garret TPJ, Clayberger C, Krensky AM, Norman AM, Littman DR, Parham P: A binding site for T-cell co-receptor CDS on the α3 domain of HLA-A2. Nature 345:41, 1990
6. Potter TA, Rajan TV, Dick II RF, Bluestone JA: Substitution at residue 227 of H-2 class I molecules abrogates recognition by CDS-dependent, but not CDS-independent, cytotoxic T lymphocytes. Nature 337:73, 1989
7. Sun J, Leahy DJ, Kavathas PB: Interaction between CDS and major histocompatibility complex (MHC) class I mediated by multiple contact surfaces that include the α2 and α3 domains of MHC class. J Exp Med 182:1275, 1995
8. Geppert TD, Wacholtz MC, Davis LS, Lipsky PE: Activation of human T4 cells by crosslinking class I MHC molecules. J Immunol 140:2155, 1988
9. Dissing S, Geisler C, Rubin B, Plesner T, Claesson MH: T coll activation. II. Activation of human T lymphoma cells by crosslinking of their MHC class I antigens. Cell Immunol 126:196, 1990
10. Geppert TD, Wacholtz MC, Patel SS, Lightfoot E, Lipsky PE: Activation of human T cell clones and Jurkat cells by crosslinking class I MHC molecules. J Immunol 142:3763, 1989
11. Skov S, Odum N, Claesson MH: MHC class I signalling in T cells leads to tyrosine kinase activity and PLC-g1 phosphorylation. J Immunol 154:1167, 1995
12. Dasgupta JD, Granja CB, Yunis EJ, Relias V: MHC class I antigens regulate CD3-induced tyrosine phosphorylation of proteins in T cells. Im Immunol 6:481, 1994
13. Geppen TD, Nguyen H, Lipsky PE: Engagement of class I major histocompatibility complex by cell surface CDS delivers an activation signal. Eur J Immunol 22:1379, 1992
14. Mittler RS, Fifer CA, Burbach P, Edinger K, Kiener PA: Evidence for a new HLA determinant that causes T cell activation without costimulation. J Immunol 145:794, 1990
15. Dasgupta JD, Yunis EJ: Receptor-like role of HLA-class I antigens: Regulation of T cell activation. J Immunol 139:672, 1987
16. Dasgupta JD, Cemach K, Dubey DP, Yunis EJ, Amos DB: The role of class I histocompatibility antigens in the regulation of T-cell activation. Proc Natl Acad Sci USA 84:1094, 1987
17. Dasgupta JD, Egea E, Relias V, Iglesias A, Gladstone P, Yunis EJ: Involvement of major histocompatibility complex class I antigens in T cell activation. Eur J Immunol 20:1553, 1990
18. Smith DM, Bluestone JA, Jeyarajah DR, Newberg MH, Engelhard VH, Thistlethwaite JR, Woodle ES: Inhibition of T cell activation by a monoclonal antibody reactive against the α3 domain of human MHC class I molecules. J Immunol 153:1054, 1994
19. De Felice M, Turco MC, Giarrusso PC, Corbo L, Pizzano R, Martinelli V, Ferrone S, Venuta S: Differential regulatory role of monomorphic and polymorphic determinants of histocompatibility leukocyte antigen class I antigens in monoclonal antibody OKT3-induced T cell proliferation. J Immunol 139:2683, 1987
20. Turco MC, De Felice M, Corbo L, Mertelsmann R, Ferrone S, Venuta S: Regulatory role of a monomorphic determinant of HLA class I antigens in T cell proliferation. J Immunol 135:2268, 1985
21. Pettersen RD, Hestdal K, Lie SO, Gaudernack G: Role of the TCR region of the HLA class I α2 domain in regulation of cell adhesion and proliferation. J Immunol 156:1415, 1996
22. Taylor DS, Nowell PC, Kornbluth J: Functional role of HLA class I cell-surface molecules in human T-lymphocyte activation and proliferation. Proc Natl Acad Sci USA 83:4446, 1986
23. Röpke M, Röpke C, Claësson MH: T-cell activation. VI. Inhibitory and stimulatory effects of anti-major histocompatibility complex class I antibodies in allogeneic mixed lymphocytes culture. Immunology 79:263, 1993
24. Bregenholt S, Röpke M, Skov S, Claesson MH: Ligation of MHC class I molecules on peripheral blood T lymphocytes induces new phenotypes and functions. J Immunol 157:993, 1996
25. Claësson MH, Dissing S, Tscherning T, Geisler C: T-cell activation. V. Anti-major histocompatibility complex class I antibody-induced activation and clonal abortion in Jurkat T-leukemic cells. Immunology 78:444, 1993
26. Amirayan N, Furrie E, Deleuil F, Mellor A, Leserman L, Machy P: Influence of MHC class I molecules on T-cell proliferation induced by CD3 or Thy-1 stimulation. Immunology 86:71, 1995
27. Woodle SE, Smith DM, Bluestone JA, Kirkman WM III, Green DR, Skowronski EW: Anti human class I MHC antibodies induce apoptosis by a pathway that is distinct from the Fas antigenmediated pathway. J Immunol 158:2156, 1997
28. lck tyrosine kinases, leads to an alternative phenotype of the TCR/CD3z-chain, and induces apoptosis. J Immunol 158:3189, 1997
29. Nagata S: Apoptosis by death factor. Cell 88:355, 1996
30. Green DR, Scott DW: Activation-induced apoptosis in lymphocytes. Curr Opin Immunol 6:476, 1994
31. Smith CA, Farrah T, Goodwin RG: The TNF receptor superfamily of cellular and viral protein: Activation, costimulation, and death. Cell 76:959, 1994
32. Itoh N, Yonehara M, Mizushima S, Samshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for the surface antigen Fas can mediate apoptosis. Cell 66:233, 1991
33. Oehm A, Berhmann I, Falk W, Pawlita M, Maier G, Klas C, Li-Weber M, Richards S, Dhein J, Trauth BC, Ponstingi H, Krammer PH: Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J Biol Chem 267:10709, 1992
34. Suda T, Takahashi T, Golstein P, Nagata S: Molecular cloning and expression of the Fas ligand, a novel member of the tumour necrosis factor family. Cell 75:1169, 1993
35. Tanaglia LA, Ayrs TM, Wong GHW, Goeddel DV: A novel domain within the 55 kDa TNF receptor signals cell death. Cell 74:845, 1993
36. Lee SY, Park CG, Choi Y: T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors. J Exp Med 183:669, 1996
37. Mollereau B, Decken M, Deas O, Rieux-Laucat F, Hirsch F, Bernard A, Fisher A, Lynch DH, Charpentier B, Le Deist F, Senick A: CD2-induced apoptosis in activated human peripheral T cells. J Immunol 156:3184, 1996
38. Wesselborg S, Prufer U, Wild M, Schraven B, Meuer SC, Kabelitz D: Triggering via the alternative CD2 pathway induces apoptosis in activated human T lymphocytes. Eur J Immunol 23:2707, 1993
39. Klaus SJ, Sidorento SP, Clark EA: CD45 ligation induces programmed cell death in T and B lymphocytes. J Immunol 156:2743, 1996
40. Gribben JG, Freeman G, Bousiotis VA, Rennert P, Jellis CL, Greenfield E, Barber M, Restivo VA, Ke X, Gray GS, Nalder ML: CTLA4 mediates antigen-specific apoptosis of human T cells. Proc Natl Acad Sci USA 92:811, 1995
41. Rammensee HG: Veto function in vitro and in vivo. Int-Rev Immunol 4:175, 1989
42. Sambhara SR, Miller RG: Programmed cell death of T cells signaled by the T cell receptor and the α3 domain of HLA class I. Science 252:1424, 1991
43. Genestier L, Meffre G, Garrone P, Pin JJ, Liu YJ, Banchereau J, Revillard JP: Antibodies to HLA class I α1 domain trigger apoptosis of CD40-activated human B lymphocytes. Blood 90:726, 1997
44. Köhler G, Milstein C: Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495, 1975
45. Tanabe M, Sekimata M, Ferrone S, Takiguchi M: Structural and functional analysis of monomorphic determinants recognized by monoclonal antibodies reacting with the HLA class I α3 domain. J Immunol 148:3202, 1992
46. Stam NJ, Spits H, Ploegh HL: Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products. J Immunol 137:2299, 1986
47. Bonnefoy-Berard N, Genestier L, Flacher M, Rouault JP, Lizard G, Mutin M, Revillard JP: Apoptosis induced by polyclonal antilymphocyte globulins in human B-cell lines. Blood 83:1051, 1994
48. Beier DC, Cox JH, Vining DR, Cresswell P, Engelhard VH: Association of human class I MHC alleles with the adenovirus E3/ 19K protein. J Immunol 152:3862, 1994
49. Vincent C, Fournel S, Wijdenes J, Revillard JP: Specific hyporesponsiveness of alloreactive peripheral T cells induced by CD4 antibodies. Eur J Immunol 25:816, 1995
50. Fournel S, Genestier L, Rouault JP, Lizard G, Flacher M, Assosou O, Revillard JP: Apoptosis without decrease of cell DNA content. FEBS Lett 367:188, 1995
51. Koopman G, Reutelingsperger CPM, Kuijten GAM, Keehnen RMJ, Pals ST, Van Oers MHJ: Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84:1415, 1994
52. Benhamou LE, Cazenave PA, Sarthou P: Anti-immunoglobulins induce death by apoptosis in WEHI-231 B lymphoma cells. Eur J Immunol 20:1405, 1990
53. Zamzami N, Marchetti P, Castedo M, Zanin C, Vayssiere JL, Petit PX, Kroemer G: Reduction in mitochondrial potential constitutes an early irreversible step of programmed cell death in vivo. J Exp Med 181:1661, 1995
54. Matsuoka S, Asano Y, Sano K, Kishimoto H, Yamushita I, Yorifuji H, Utsuyama M, Hirokawa K, Tada T: A novel type of cell death of lymphocytes induced by a monoclonal antibody without participation of complement. J Exp Med 181:2007, 1995
55. Genestier L, Paillot R, Bonnefoy-Berard N, Waldmann H, Revillard JP: T cell sensitivity to HLA class I-mediated apoptosis is dependent on IL-2 and IL-4. Eur J Immunol 27:495, 1997
56. Amirayan N, Vernet C, Machy P: Class I-specific antibodies inhibit proliferation in primary but not secondary mouse T cell responses. J Immunol 148:1971, 1992
57. Dhein J, Walczak H, Baumler C, Debatin K, Krammer PH: Autocrine T cell suicide mediated by APO-1/(Fas/CD95), Nature 373:438, 1995
58. Zheng L, Fisher G, Miller RE, Peschon J, Lynch DH, Lenardo MJ: Induction of apoptosis in mature T cells by tumor necrosis factor. Nature 377:348, 1995
59. Kabelitz D, Pohl T, Pechold K: Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes. Immunol Today 14:338, 1993
60. Dhein J, Daniel PT, Trauth BC, Oehm A, Möller P, Krammer PH: Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens. J Immunol 149:3166, 1992